The value of exports of commodity group 293391 "Heterocyclic compounds; alprazolam (INN), camazepam (INN), chlordiazepoxide (INN), clonazepam (INN), clorazepate, delorazepam (INN), diazepam (INN), estazolam (INN), ethyl loflazepate (INN), fludiazepam (INN), flunitrazepam (INN), (cont)" from Japan totalled $ 1.13 million in 2023. Sales of commodity group 293391 from Japan decreased by 24% in value terms compared to 2022. exports of commodity group 293391 "Heterocyclic compounds; alprazolam (INN), camazepam (INN), chlordiazepoxide (INN), clonazepam (INN), clorazepate, delorazepam (INN), diazepam (INN), estazolam (INN), ethyl loflazepate (INN), fludiazepam (INN), flunitrazepam (INN), (cont)" decreased by $ 376 thousand (cumulative exports of commodity group 293391 from Japan amounted $1.51 million in 2022)
Exports of commodity group 293391 amounted to 0.007% of total sales of group "" from Japan in 2023 (the value of exports of commodity group from Japan amounted to $14.7 billion in 2023). The share of exports of commodity group 293391 in sales of commodity group from Japan lowered by 0.001 p.p. compared to 2022 (it was 0.008% in 2022, and exports of commodity group from Japan were $17.1 billion).
Exports of commodity group 293391 amounted to 0.099 percent of total sales of group "" from Japan in 2023 (the value of exports of commodity group from Japan amounted to 1.14 billion USD in 2023). The share of exports of commodity group 293391 in sales of commodity group from Japan lowered by 0.012 p.p. compared to 2022 (it was 0.112 percent in 2022, and exports of commodity group from Japan amounted to 1.34 billion USD).
Top export destinations of "Heterocyclic compounds; alprazolam (INN), camazepam (INN), chlordiazepoxide (INN), clonazepam (INN), clorazepate, delorazepam (INN), diazepam (INN), estazolam (INN), ethyl loflazepate (INN), fludiazepam (INN), flunitrazepam (INN), (cont)" from Japan in 2023:
The value of imports of commodity group 293391 "Heterocyclic compounds; alprazolam (INN), camazepam (INN), chlordiazepoxide (INN), clonazepam (INN), clorazepate, delorazepam (INN), diazepam (INN), estazolam (INN), ethyl loflazepate (INN), fludiazepam (INN), flunitrazepam (INN), (cont)" to Japan totalled $ 3.87 million in 2023. Sales of commodity group 293391 to Japan decreased by 0.179% in value terms compared to 2022. imports of commodity group 293391 "Heterocyclic compounds; alprazolam (INN), camazepam (INN), chlordiazepoxide (INN), clonazepam (INN), clorazepate, delorazepam (INN), diazepam (INN), estazolam (INN), ethyl loflazepate (INN), fludiazepam (INN), flunitrazepam (INN), (cont)" decreased by $ 6.98 thousand (the value of imports of commodity group 293391 to Japan was equal to $3.88 million in 2022)
Imports of commodity group 293391 reached 0.025% of total imports of group "" to Japan in 2023 (imports of commodity group to Japan totalled $15.3 billion in 2023). The share of purchases of commodity group 293391 in total imports of commodity group to Japan increased by 0.004 p.p. compared to 2022 (it was 0.021% in 2022, and imports of commodity group to Japan accounted for $18.2 billion).
Imports of commodity group 293391 reached 0.167 percent of total imports of group "" to Japan in 2023 (imports of commodity group to Japan totalled 2.31 billion USD in 2023). The share of purchases of commodity group 293391 in total imports of commodity group to Japan increased by 0.012 p.p. compared to 2022 (it was 0.155 percent in 2022, and imports of commodity group to Japan accounted for 2.49 billion USD).
Top trading partners (import of "Heterocyclic compounds; alprazolam (INN), camazepam (INN), chlordiazepoxide (INN), clonazepam (INN), clorazepate, delorazepam (INN), diazepam (INN), estazolam (INN), ethyl loflazepate (INN), fludiazepam (INN), flunitrazepam (INN), (cont)") of Japan in 2023: